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ABSTRACT 
 
 
 
 
According to the National Heart Lung and Blood Institute, more than 
30,000 newborns in the United States are born with Congenital Heart Defects 
(CHDs) every year. The Total Cavo-pulmonary Connection (TCPC) or the Fontan 
operation is a widely employed procedure to palliate CHD conditions. Two 
variants of this procedure are currently in use namely the intra-atrial TCPC and 
the extra-cardiac TCPC. Determining which of these procedures is 
hemodynamically favorable has been elusive clinically. One characteristic which 
may distinguish the two is power loss, estimated using computational fluid 
dynamic (CFD) analysis.  
It is our hypothesis that the extra-cardiac Fontan is more hemodynamically 
favorable compared to the lateral tunnel Fontan, due to decreased vortex 
formation, decreased flow collision, less eccentric flow and thus lower viscous 
dissipation. We performed steady flow CFD simulations on 3-D anatomical 
reconstructions of total cavo-pulmonary connections (TCPC) from 11 Fontan 
patients using cardiac magnetic resonance imaging (CMR) data, 5 with extra-
cardiac and 6 with lateral tunnel intra-atrial Fontans. Caval flows were 
determined using CMR velocimetry and outlet pressures were tuned for both the 
left and right pulmonary arteries in order to yield three different flow splits: equal 
flow to each lung, equal lung resistance of 2 Woods units, and CMR-measured.   
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Power loss calculations using control volume analysis were performed for 
each TCPC and each flow condition studied. Power losses were normalized to 
cardiac output and the two groups compared using the Student t-test for two 
independent groups. The lowest power losses were seen in the equal lung 
resistance condition, where power loss in the EC TCPC was 0.91±0.70 
mW/l/min, compared to 3.3±1.3 mW/l/min for the IC TCPC. Power losses were 
similar for the other flow conditions. This difference between EC and IC TCPC 
was statistically significant for each flow split studied (p<0.01 for all splits 
studied). CFD modeling of 3-D anatomical reconstructions demonstrates 
differences in power loss between EC and IC TCPC, indicating that the EC 
Fontan may be more energetically favorable. More studies are required to 
determine whether these differences are universal. These differences may be 
important in the long-term survival and quality of life of patients with TCPC. 
My specific role in this project began at the CFD stage in terms of using 
the various CFD tools and ended in the power loss analysis and visualizing the 
flow fields using Tecplot. I have not been involved in the imaging part of this 
study which took place at CHOP and the images were processed at the CFMG 
lab at Georgia Tech.  
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CHAPTER 1: INTRODUCTION 
 
  
 
 
 According to the National Heart Lung and Blood Institute, more than 
30,000 newborns in the United States are born with Congenital Heart Defects 
(CHDs) every year. The incidence of children born with a uni-ventricular heart 
condition, in which only one of the heart’s pumping chambers is functional, is 
about 2 out of every 1000 births. In children with such abnormal anatomies, there 
occurs a mixing of oxygenated and deoxygenated blood in the same heart 
chamber. 
A palliative procedure involving the separation of the systemic and 
pulmonary circulations in order to avoid venous blood mixing was suggested by 
Fontan and Baudet in 1971 [1]. The main target of this surgical procedure was to 
bypass the single ventricle and allow a passive flow of blood returning from the 
systemic circulation to the pulmonary arteries and thus, to the lungs. This 
procedure underwent several modifications since it was introduced; each 
modification aimed at improving post-operative mortality rates and the procedure 
came to be known as the Fontan procedure. 
Studies regarding the surgical outcomes of the Fontan procedure 
suggested a functional decrease of cardiac functions on a long-term basis in 
post-operative patients [2]. While there have been many advances over the past 
20 years in the management of patients with single ventricle physiology, it 
      
                         
 
                                                                                                                                 2 
 
appears that even the patients with excellent short-term outcomes will often 
develop significant complications in the second and third decades of life.  These  
complications include debilitating problems like significant heart failure and 
Protein Losing Enteropathy (PLE).   
The currently accepted technique of managing single ventricle patients 
generally involves three stages of surgery which culminate in the Total Cavo-
Pulmonary Connection (TCPC). While the initial procedure described by Fontan 
involved connecting the right atrium to the pulmonary arteries in order to redirect 
venous flow to the pulmonary arteries, subsequent revisions have generally 
excluded the atria from the circuit.  While there have been many modifications to 
the procedure since it was first described, the principal remains the same: The 
blood is pumped to the systemic circulation by the single ventricle.  The systemic 
venous return drains directly into the pulmonary arteries.  Thus the driving force 
for blood across the lungs is the systemic venous pressure minus the ventricular 
filling pressure of the heart.  
The Fontan operation has undergone many modifications since it was 
originally performed in 1971. The general aim of all these modifications was to 
improve the hemodynamics in the surgical connection so as to improve patient 
mortality. The Intra-atrial TCPC was introduced by de Leval et al in 1988 [9] and 
has been gaining widespread use since then because of the ease of 
performance of the surgery and due to the contention that the elimination of the 
right atrium in the patient would lead to greater hemodynamic efficiency and 
lesser right atrium related complications. The exact details of the surgery have 
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explained at length in the following chapter. But several studies later have 
described various moderate to late complications related to the intra-atrial TCPC, 
like thrombus formations, Protein Losing Enteropathies (PLEs) and reduced 
cardiac output states [12] [36] [37]. A majority of these complications were 
attributed to the extensive intra-atrial sutures and the placement of prosthetic 
materials in the atrium [21]. This led researchers to look for new alternatives to 
the intra-atrial TCPC.  
The Extra-cardiac TCPC is a relatively new surgical procedure that has 
been gaining importance as a surgical alternative to the intra-atrial TCPC 
because it is technically simpler and offers the possibility of eliminating the usage 
of any thombogenic intra-atrial material [12]. There is still a debate in the medical 
community regarding the superiority of one procedure over another and there is a 
need to conduct further studies to compare the two procedures so that the 
physician is provided a good rationale for choosing a particular procedure. In this 
context, this study which is aimed at comparing the hemodynamic efficiencies of 
both the procedures, gains significant importance.      
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CHAPTER 2: BACKGROUND 
 
 
 
 
 To better understand single ventricular diseases, it is important to know 
the normal human heart physiology and circulation. This chapter is intended to 
focus on explaining the functional differences between the normal heart and the 
single ventricular heart physiologies. 
 
2.1  The Normal Cardiovascular System  
 In the simplest terms, the heart is the most important blood pumping 
chamber in the human body, transporting oxygenated blood to various organs 
and tissues and receiving the deoxygenated blood from the body. In general, the 
human circulatory system can primarily be divided into two circuits as the 
systemic and the pulmonary circulations. The former involves carriage of blood 
from the heart to the rest of the body while the latter describes the transport of 
blood between the chambers of the heart to the lungs and back. 
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Figure 2.1.1: Normal Human Circulatory Physiology 
http://www.nsbri.org 
 
 
 
 In the normal heart, the Inferior and the Superior Vena Cavae (the IVC 
and the SVC respectively) bring the systemic blood into the Right Atrium (RA) of 
the heart from where the blood flows down into the Right Ventricle (RV), through 
the Tricuspid Valve. From the RV, the blood is transported through the 
Pulmonary Valve into the Pulmonary Artery (PA) where the blood gets 
oxygenated in the lungs and is sent back to the Left Atrium (LA) and then through 
the Mitral Valve into the Left Ventricle (LV) from where the blood enters the 
systemic circulation through the Aorta. 
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Figure 2.1.2: Blood flow schematic inside a normal heart 
http://www.nhlbi.nih.gov 
 
 
 
2.2 Congenital Heart Defects and Univentricular Physiologies 
A Congenital Heart Disease (CHD) is a structural malformation or a 
functional abnormality of the heart present at birth and usually starts developing 
during the neo-natal stage. CHDs can be associated with Atrial or Ventricular 
Septal Defects, Aortic or Pulmonary Valve Stenoses, Hypoplastic Left Heart 
Syndrome (HLHS), Aortic Regurgitation or the Tetralogy of Fallot and can cause 
the blood flow to either stop completely or slow down or get totally directed to a 
wrong place. 
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Figure 2.2.1: Hypoplastic Left Heart Syndrome is a condition in which the left 
part of the heart is severely underdeveloped [Mayo Clinic] 
 
 
 
A child with a single ventricle has only one working ventricle and most 
often, there is a second, small non-functioning ventricle. Oxygenated and 
deoxygenated blood mix within the single ventricle, allowing oxygenated blood to 
reach the body. If there is too much blood flow to the lungs the baby may develop 
congestive heart failure with symptoms of poor feeding, clammy sweating, fast 
breathing, low energy, cyanosis and slow growth.  
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Figure 2.2.2: Diagrammatic representation of a single ventricular heart [Adult 
Congenital Heart Association]  
 
 
 
From a biomechanical view point, while in the normal heart there are two 
functional pumping ventricular chambers, one to push the blood into the lungs 
and the other to push it into the systemic circulation, in a single ventricular heart, 
the only pumping chamber bears the maximum load leading to a series of 
complications involving reduced pumping efficiency of the heart and lowering the 
blood oxygen levels. While the arterial oxygen saturation levels may return to 
normal and a reduction in the long-term volume load placed on the systemic 
ventricle may prevent the development of atrio-ventricular valve regurgitation and 
ventricular failure, the absence of any valves causes the dependence of blood 
flow solely on the pressure gradient between the systemic veins and the left 
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atrium [4]. Any surgery aimed at rectifying or palliating this condition should 
consider the power losses occurring inside the post-surgical baffles.  
 
2.3 Single Ventricle Heart Repairs 
 This section will discuss the various surgical procedures that have been 
developed over the years to palliate the shortcomings of the SV physiology. 
2.3.1 The Fontan Operation and its aftermath 
In the original surgery performed by Fontan and Baudet in 1971, the right 
atrium was connected directly to the pulmonary artery and the ASD closed. Blood 
entering the right atrium from the veins passed across this surgical connection 
into the pulmonary artery and to the lungs, thus bypassing the right ventricle 
completely. Several modifications to this procedure over the years that were 
aimed at improving the patient mortality rates are described in the following sub-
sections. 
2.3.2 The Atrio-pulmonary (AP) Connection 
The first of a series of modifications to the original Fontan procedure was 
described by Kreutzer et al in 1973. They demonstrated a procedure where the 
entire venous drainage was diverted to the pulmonary system using an A-P 
connection. Long-term follow-ups of these patients showed some trends of 
ventricular arrhythmias, atrial thrombi and lowered exercise abilities [6].  
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Figure 2.3.2: The Atrio-pulmonary connection with the ASD closed and the SVC and 
IVC draining into LPA and RPA [7]  
 
 
 
2.3.3 The Total Cavo-pulmonary Connection (TCPC) 
While there have been many advances over the past 20 years in the 
management of patients with single ventricle physiology, it appears that even the 
patients with excellent short-term outcomes will often develop significant 
complications in the second and third decades of life.  These complications 
include such debilitating problems as significant heart failure and protein losing 
enteropathy.  The currently accepted technique of managing single ventricle 
patients generally involves three stages of surgery which culminate in the total 
cavo-pulmonary connection (TCPC).  
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Stage 1: Norwood Procedure 
This procedure is performed immediately after birth. In this procedure, in 
the case of a stenosed aorta in the newborn, the aorta is reconstructed using the 
pulmonary root, the ascending aorta, and if needed, a cryo-preserved homograft 
tissue [8].  
 
 
 
 
Figure 2.3.3: Stage 1 of TCPC – The Norwood Procedure. Step 1 is the 
reconstruction of the aorta. Step 2 is placing the Blalock-Taussig Shunt. Step 3 is the 
removal of the wall between the atria. [The University of Michigan Congenital Heart 
Center] 
 
To control pulmonary blood flow, a shunt, often called the Blalock-Taussig 
Shunt, is then placed in between the pulmonary and systemic arteries. The 
Norwood procedure helps to re-route blood flow to and from the lungs, keeping 
the heart functioning until all the three stages of the surgery are completed. 
      
                         
 
                                                                                                                                 12 
 
Stage 2: Hemi-Fontan or the Bidirectional Glenn (BDG) 
 This procedure is normally performed in children four to six months 
of age. It involves removing the Blalock-Taussig Shunt and the SVC is connected 
to the PAs. A patch is placed over the RA which prevents blood from the upper 
body from entering the heart and blood from the IVC from entering the lungs.  
 
 
 
 
Figure 2.3.4: Stage 2: Hemi-Fontan of Bi-directional Glenn Shunt. Step 1 is the blood 
from the SVC sent to the LPA and the RPA. Step 2 is the removal of the Blalock-Taussig 
Shunt. Step 3 is placing a patch in the RA. [The University of Michigan Congenital Heart 
Center] 
 
A hemi-Fontan procedure is not usually performed on a newborn because 
the blood returning from the SVC is unable to enter the PAs due to the high blood 
pressure in the pulmonary arteries of the neonate. 
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Stage 3: The Total Cavo-Pulmonary Connection (TCPC) 
The patch that was placed in the right atrium is removed 
and a baffle is built in the RA. The baffle guides the blood from the IVC into the 
pulmonary arteries. A small hole, called a fenestration, is made in the baffle 
which allows a small amount of de-oxygenated blood to go across the baffle into 
the right upper chamber in case the pressure in the lungs gets too high.  
 
 
 
 
Figure 2.3.5: Stage 3: The Total Cavo-Pulmonary Connection. Step 1 is the 
removal of the patch from the RA. Step 2 is building a wall in the RA. Step 3 is leaving a 
fenestration in the baffle (wall). [The University of Michigan Congenital Heart Center] 
 
The size of this fenestration may vary. For most children, a small hole is 
made that will close by itself over time. In some children, a larger hole is needed. 
Closure of large holes is usually done six to twelve months later during a heart 
catheterization. 
      
                         
 
                                                                                                                                 14 
 
 
2.3.4 Intra-atrial (IC) and Extra-cardiac (EC) TCPCs 
This section will describe two variations of TCPC procedures that are 
currently in use, listing the advantages and disadvantages of each. 
The Intra-atrial TCPC 
   All variations of the Fontan operation are designed to direct systemic 
venous return to the pulmonary arteries in patients with a functional single 
ventricle. de Leval et al [9] in 1988 first described the intra-atrial or the intra-
cardiac Fontan operation in which a corridor of lateral right atrium is directed from 
the IVC to the SVC using an artificial tube. The return from the SVC to the RPA is 
re-established after having been interrupted during the hemi-Fontan procedure. 
An intra-atrial baffle is placed to channel blood from the IVC orifice up to the SVC 
orifice. Two anastomoses are created between the SVC and the right pulmonary 
artery to channel SVC blood and IVC blood separately into the pulmonary 
circulation. This is also referred to as a "Lateral Tunnel" Fontan. 
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Figure 2.3.6: The Intra-Cardiac Fontan: An artificial tunnel is constructed between the 
SVC and the IVC, using a part of the right atrium. The fenestration is often required in 
patients to prevent the build up of high pressures in the lungs. This fenestration usually 
closes by itself over time or would sometimes need a cardiac catheterization procedure 
for closure. The eventual blood flow direction pattern is as shown in the figure [10] 
 
 
 
Previous clinical studies have suggested some advantages as well as 
disadvantages of the intra-cardiac lateral tunnel TCPC. The procedure requires 
cross -aortic clamping and in some cases, a complete cardio-plegic arrest and 
poses a high risk of thrombo-embolism in the long run [11]. The placing of an 
intra-atrial baffle has been shown to increase post-operative risks including late 
atrial arrhythmias [12] [13] 14].  
 
The Extra-cardiac (EC) Fontan 
Another relatively recent variation of TCPC that is gaining increasing 
acceptance is the Extra-cardiac Fontan introduced in1990 [15]. In this procedure, 
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the superior vena cava is connected to the right pulmonary artery and the inferior 
vena cava is re-routed through a Gore-Tex conduit, which runs outside the heart 
and is connected to the left and the right pulmonary arteries. Thus, the blood 
returns via the pulmonary veins into the left atrium and may also pass to the right 
atrium freely and then to the left ventricle, then the aorta and to the systemic 
circulation. 
 
 
Figure 2.3.7: Diagrammatic representation of the EC Fontan.  
 
Clinically, the extra-cardiac conduit procedure has been shown to offer 
several advantages, which include the preservation of normal atrial pressure and 
avoiding extensive intra-atrial suture lines [16]. In many cases, it also eliminates 
the need for a total cardiopulmonary bypass (CPB). However, this procedure has 
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potential disadvantages related to using the extra-cardiac tube, including the lack 
of growth potential, conduit stenosis owing to intimal peel formation, an increased 
risk of thromboembolism and may raise the need for a re-operation on the patient 
[17].  
Overall, both the procedures thus have their own merits and de-merits over 
one another. However, the choice of choosing between the EC and the IC TCPC 
procedures is still largely a decision made by the surgeon. 
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CHAPTER 3: AIMS AND OBJECTIVES 
 
 
 
3.1      General Objectives 
As discussed in the previous sections, the style construction of the TCPC 
is a very important factor in determining the success of the Fontan procedure. 
Previous studies indicate that the geometry of the TCPC plays a critical role in 
the internal hemodynamics of the Fontan connection [18]. Previous work using in 
vitro and computational fluid dynamic techniques have demonstrated that relatively 
subtle differences in the TCPC geometry can result in significant differences in 
power loss through the circuit.  These differences can largely be attributed to 
differences in the extent to which collision occurs between the SVC and IVC flows 
into the pulmonary arteries.  Another factor that plays a significant role in power loss 
is the differential flow into each pulmonary artery.  A disproportionate amount of 
blood flow through one of the pulmonary arteries results in increased power loss. 
Some studies [19], [20] have suggested that modifications to the geometry like 
adding a slight curvature at the vena caval inlets and flaring at the anastomoses 
may have a significant impact on energy losses in the connection. Data gathered 
from studies at Georgia Tech and the Children’s Hospital of Philadelphia has 
demonstrated vortex formation and other chaotic flow behaviors in the region where 
the superior vena cava and the Fontan baffle connect to the pulmonary artery. This 
flow phenomenon directly contributes to the overall power loss and many attempts 
have been made to optimize the Fontan baffle geometry to minimize this loss. A 
study by this group on power loss and flow dynamics in the systemic venous 
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pathway was first performed in vitro by Sharma et al [18] [20]. The geometry of the 
pathway was studied using glass models based on in vivo cardiac MRI geometric 
data and flow was visualized with Amberlite particles recorded on video. The position 
of the superior vena cava relative to the Fontan baffle was varied by fractions of SVC 
diameters with various flow rates in the branch pulmonary arteries. When the Fontan 
baffle connected in-line with the IVC, energy losses were almost double compared to 
the 1 and 1.5 times diameter offset, which had the lowest energy loss. Flow 
visualization indicated that the energy loss was as a result of the “chaotic” flow 
pattern seen at the zero offset flow condition. In addition, energy savings were more 
evident at an equal split of flow between right and left pulmonary arteries and energy 
losses increased with increased total flow. Hybrid geometries have also been 
studied for their energy losses. 
As for the choice between an IC and EC TCPCs, it is still very patient 
specific and often rests upon the surgeon’s decision. A number of studies have 
been performed to compare the power losses in these connections. Lardo et al 
have shown that the extra-cardiac Fontan shows significantly lower power losses 
compared to the intra-cardiac Fontan. Also, offsetting the extra-cardiac conduit 
towards the distal right pulmonary artery showed a further decrease in power 
losses [21].  Recent advances in medical image acquisition and numerical 
methods for solving the Navier-Stokes equations have created new vistas to 
develop reliable computational fluid dynamics (CFD) tools to meeting patient 
specific surgical planning objectives [22]. These tools can now be used as an 
effective means to accurately determine the energy losses in TCPCs.  
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This study demonstrated the potential use of computer-aided design and 
numeric simulations for surgical planning purposes. While much work has been 
done in investigating the fluid dynamics and power losses of the TCPC, there is little 
work done to show that these differences make a clinical difference. Increased 
power loss affects the clinical condition and is a vital parameter to focus on in the 
effort to improve the TCPC. Our goal continues to be to refine the techniques of 
estimating power loss in the Fontan circulation.   
 
3.2 Specific aim of the study 
As mentioned in the previous section, preliminary experiments, specially 
by the Fontan Research Group at Georgia Institute of Technology suggest that 
differences in the geometry of the TCPC can make significant differences in the 
power loss in the circuit [18] [19] [20].  To date, a systematic evaluation of the 
difference between extra-cardiac and intra-cardiac lateral-tunnel anatomies using 
anatomically correct patient reconstructions has not been performed. By 
evaluating a series of patients with both intra-atrial and extra-cardiac Fontans, we 
intended to determine whether there are any real differences between actual 
TCPC reconstructions such that one type (EC or IC) may be hemodynamically 
superior to the other.  This was accomplished by using the TCPC reconstructions 
from a series of extra-cardiac and intra-cardiac Fontan patients.   
These were used to generate computational models and solve for the 
MRI-measured flow conditions.  The power loss was calculated for each model 
and used to characterize the efficiency of each TCPC. By comparing the intra-
cardiac and extra-cardiac Fontan patients, it is hoped that the surgeon will be 
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able to determine whether one surgical strategy creates more favorable 
hemodynamics than the other.  This information should be extremely valuable 
and would allow for more informed decision-making by surgeons as to which 
procedure to perform.  Furthermore, this work is hoped to create a foundation for 
the use of high resolution imaging and computer modeling to make medical and 
surgical decisions for many different types of heart diseases. 
 
3.3 My Specific Role 
While there have been studies previously with regards to the comparison 
of the IC and the EC TCPCs from a fluid mechanical point of view [21] and 
studies that have demonstrated the use of Computational Fluid Dynamics as a 
means to evaluate the power losses in vitro [24], there have not been many 
studies that have focused on the comparison of the power losses specifically with 
regards to the IC and the EC connections. For example, Migliavacca et al [24] 
have demonstrated the use of CFD as an effective means to evaluate the 3-D 
geometries and have even showed the effects of an inferior caval anastomosis 
on the geometry using CFD techniques.  
In this context, my specific aim of the study was to compare the power 
losses in both the IC and the EC connections using a Computational Fluid 
Dynamics approach. My role in this study was to process the obtained MRI 
images into a realistic 3-D model that would be used for the CFD analysis and 
then to perform the CFD analysis on these models to evaluate and compare the 
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power losses in both the connections. For these purposes, I used various CFD 
tools like GAMBIT, FIDAP and Tecplot.  
GAMBIT is a software tool to mesh the 3-D model while FIDAP is a 
commercially available CFD package used to run the CFD codes (included in the 
appendix). Tecplot was used to visualize these flows based on the data obtained 
from subjecting the 3-D model to the codes in FIDAP. The hypothesis for this 
study was that the extra-cardiac Fontan has fewer flow collisions and vortex 
dissipation, and thus lower power losses than the lateral tunnel or intra-atrial 
TCPC.  
More specifically, I started off with the 3D reconstructed images and the 
corresponding MRI flow rates for each of the models that were provided by the 
CFMG lab at Georgia Tech. I imported these geometries into GAMBIT and 
meshed them using a set of pre-determined parameters that are detailed in the 
appendix. This prepared for the models to be imported into FIDAP for further 
CFD analysis. This mesh was then imported in FIDAP, where the boundary 
conditions are specified with respect to the inlets and the outlets of the model. 
Then, the model was run in FIDAP for about 6000 iterations till the solutions were 
reasonably converged and the residuals of the solutions were at a minimum.  
I then used the forces, areas and pressures that were outputted from 
FIDAP to perform my power loss calculations. These power losses were 
normalized to the Cardiac Outputs, since it was a parameter that determined the 
amount of power losses across all the patients, which was called the Head Loss 
(in mmHg). These head losses were further normalized to the Cardiac Index of 
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each of the patients, which lead to a value in Woods Units that was least 
sensitive to the flow.      
Also, the results from FIDAP were imported into Tecplot for the purpose of 
visualizing the flow fields. Each of the EC and IC models were visualized using 
this tool that allowed us to determine the etiologies of the flow differences that 
occurred in the EC and the IC connections. A detailed analysis of these results is 
presented in the results section. 
 
 
 
 
 
  
      
                         
 
                                                                                                                                 24 
 
 
CHAPTER 4: MATERIALS AND METHODS 
 
 
 
4.1 Basis for using CFD techniques to calculate power losses in TCPC 
Studying ways to minimize the power loss relies on complex modeling 
using CFD employing finite element techniques. These calculations depend upon 
the Navier-Stokes equations and the goal is to predict velocity, pressure and flow 
as a function of time and position. In one study by de Leval et al., CFD was used 
to determine flow and energy dissipation with various offsets of superior vena 
cava and the Fontan baffle [23] [24], similar to the in-vitro work of Ensley et al 
[20].  
CFD offers the ability to design the geometry of the systemic venous 
pathway to optimize blood flow and minimize the energy loss. CFD modeling was 
employed to investigate power loss in extra-cardiac Fontan baffles with a 
comparison to the intra-atrial lateral wall tunnel type Fontan [21]. The study used 
4 different extra-cardiac conduit models with different lengths of the inferior 
anastomosis and inclinations of the conduit. Power loss was highest with the 
larger anastomosis than with the smallest.  
Lardo et al. also investigated the power loss in extra-cardiac conduits and 
compared it to the power loss in extra-cardiac tunnels and intra-atrial lateral wall 
tunnels using explanted sheep hearts at flows of 1-6 L/min. Fluid power losses 
were consistently lower for the extra-cardiac conduits than the other two 
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configurations. If the extra-cardiac conduit was optimized with a 5 mm offset to 
the right pulmonary artery, an additional 36% reduction in power loss was noted.  
The extra-cardiac tunnel and intra-atrial lateral wall tunnel were least efficient 
with losses 73% greater than the optimal extra-cardiac conduit.  
The validation of CFD modeling was undertaken in single ventricle patients 
after Fontan by Migliavacca et al., who used cardiac MRI anatomic information to 
build the CFD model and velocity mapping to validate the model. A number of 
assumptions were built into the CFD model including the absence of vessel wall 
compliance and respiratory variation. Nevertheless, there was good agreement 
between the CFD model and the MRI in vivo data. The investigators concluded 
that CFD models of the TCPC based on preoperative anatomy could be used to 
predict postoperative hemodynamics [23] [24] [25]. This is critical, as CFD could 
then be used as a predictor of post-operative hemodynamics and thus the 
outcome. 
The Fontan research group (CFMG, headed by Dr. Ajit Yoganathan) at 
Georgia Tech previously developed a technique in which a three dimensional 
reconstruction of a patient’s TCPC anatomy can be obtained using MRI data.  In 
addition, using through-plane phase-encoded velocity mapping, detailed velocity 
maps can be obtained at the inlets and outlets of the TCPC i.e., the SVC, IVC 
and RPA, LPA respectively.  Using this data, a 3-D mesh can be constructed 
which is compatible with finite element analysis software.  Using the finite 
element analysis software, the fluid dynamics of the circuit can be fully 
investigated and the power loss of the circuit determined under varying flow 
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conditions.  This method has been validated by in vitro experiments using both 
idealized models and actual 3-D reconstructions from the MRI data employing 
proprietary resins and a stereo lithography technique [26] [27] [28].  The power 
loss calculated via CFD solutions from FIDAP, a commercially available CFD 
software package, using a second order solver showed agreement within 5-10% 
of the in vitro data [22] [28] [29] [30].  
 
4.2 Methods 
4.2.1 Patient Recruitment 
Patients who were already enrolled in the Fontan study were identified. 
Subjects were selected that have adequate MRI data to perform a computational 
analysis. From the current data, in the database collected at Children’s Hospital 
of Philadelphia (CHOP) or Children’s Hospital of Atlanta (CHOA), 13 patients 
have been identified and analyzed for the extra-cardiac vs. intra-cardiac power 
loss analysis. 
 
4.2.2 Cardiac MRI (CMR)  
The basis of MRI is the directional magnetic field, or moment, associated 
with charged particles in motion. Nuclei containing an odd number of protons 
and/or neutrons have a characteristic motion or precession. Because nuclei are 
charged particles, this precession produces a small magnetic moment. When a 
human body is placed in a large magnetic field, many of the free hydrogen nuclei 
align themselves with the direction of the magnetic field. The nuclei move about 
the magnetic field direction like gyroscopes. This behavior is termed Larmor 
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precession. The frequency of Larmor precession is proportional to the applied 
magnetic field strength as defined by the Larmor frequency, ω0: 
 
ω0 =γ. B0 
 
where γ is the gyromagnetic ratio and B0 is the strength of the applied magnetic 
field. The gyromagnetic ratio is a nuclei specific constant. For hydrogen, γ = 42.6 
MHz/Tesla. 
 
 
 
 
Figure 4.1: In the absence of a strong magnetic field, hydrogen nuclei are randomly 
aligned as in (a). When the strong magnetic field B0 is applied, the hydrogen nuclei 
precess about the direction of the field as in (b). 
 
 
 
To obtain an MR image of an object, the object is placed in a uniform 
magnetic field, B0, of between 0.5 to 1.5 Tesla. As a result, the object's hydrogen 
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nuclei align with the magnetic field and create a net magnetic moment, M, 
parallel to B0. 
The first MRI images of the heart were produced more than 20 years ago. 
Since that time, cardiac MRI techniques have progressively improved. With these 
impressive advances in spatial and temporal resolution and increased imaging 
speed, cardiac MRI has become one of the most valuable diagnostic tools for 
heart disease, especially over the past 5 years. Because of the advantages of 
cardiac MRI over other techniques used in heart-disease assessment, cardiac 
MRI is beginning to be used routinely at specialized centers. Some studies have 
pointed out the effective use of two and three dimensional MRI techniques as a 
useful tool to assess congenital heart defect anatomies and post-operative 
surgical constructs [32]. 
Magnetic spins of intravascular protons that flow along a magnetic field 
acquire a phase-shift that is proportional to velocity. When the phase shift is 
measured, velocity of blood flow is derived. The measurement of the phase shift 
requires specific signal amplitude and multiple gradient echo sequences that 
have been developed to provide high signal intensity. A phase-shift velocity 
quantification method called Velocity-Encoded Cine Magnetic Resonance 
Imaging (VEC MR) measures velocity and flow. In this method, a gradient echo 
sequence with flow compensation is used to preserve signal amplitude from a 
region of flow.  The signal is encoded with velocity by slightly modifying the 
gradient wave form, thereby inducing a phase shift in spins that move or flow 
along this gradient.  The phase shift accumulated by the MRI signal obtained 
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from a specific voxel is proportional to the flow velocity within that voxel.  The 
direction of flow and the direction of velocity encoding are aligned with the use of 
oblique magnetic field gradients. On a phase image, the gray value of the pixel 
represents the phase of magnetization. Combined with phase-error correction 
techniques, velocity can be accurately measured. 
 Velocity maps were collected during the cardiac cycle and quantitative 
data are obtained in a region of interest (ROI) that was traced along the margins 
of the blood vessel and tailored to the vessel contours. The computer analysis 
converts the average and peak phase values to average and peak velocities. 
Instantaneous volume flow is computed from the product of the average flow 
velocity and ROI area. Since manual segmentation and tracing could be time-
consuming as well as prone to errors such as inclusion of noise, the semi-
automated approach developed at Georgia Tech were adopted for the purpose of 
segmentation, flow reconstruction, and evaluation of the hemodynamic 
measurements.  
 
4.2.3 CFD Methods 
The MRI data was used to create a computational mesh. This was 
accomplished using a series of steps developed in previous work using both 
proprietary and commercially available software.  The first step involves defining 
the borders of the vessels from the anatomical MRI data using edge detection 
software developed at Georgia Institute of Technology. 
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The first step towards the establishment of an anatomical database was to 
reconstruct 3D patient-specific anatomies based on stacks of sparsely sampled 
CMR images. The approach may be split into 3 major steps that all required 
significant technology development:  
1. Interpolation,  
2. Segmentation, and  
3. 3D Reconstruction. 
Interpolation:  
CMR data usually have a better in-plane than through-plane spatial 
resolution, resulting in non-isotropic voxels which is detrimental to the following 
segmentation and reconstruction steps.  A novel interpolation method, adaptive 
control grid interpolation (ACGI), was developed at Georgia Tech that was shown 
to perform better than traditional interpolation strategies using either spline or 
linear interpolation schemes [30] [33] [34].  
Segmentation: 
 After interpolation, the vessels of interest are segmented out of the 
enhanced MRI dataset, isolating the TCPC structure from the rest of the thorax. 
This was done using a shape element segmentation technique, called bouncing-
ball algorithm.  
In this approach the MR image may be considered as a 3D map, where 
the slope is dictated by the intensity gradients of the MRI rather than by the 
changes in elevation. Large changes in intensity (when going from a vessel 
lumen to the surrounding tissues for example) appear as steep slopes, whereas 
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regions of uniform intensities appear as valleys. A segmentation element or ball 
is released in the lumen of the vessel of interest, with an initial random velocity. It 
bounces against the steep slopes which correspond to the vessel walls until the 
whole vessel lumen is segmented. A larger ball will segment the vessel faster as 
well as ensure that the segmentation does not leak into nearby vessels, while a 
smaller ball could segment much smaller vessels, but has the risk of capturing 
surrounding regions.  
In practice, a spherical shape element with a radius of 2.5 pixels was 
preferentially used, as it was the smallest element of that configuration that 
described a spherical profile reasonably well. When this element size proved too 
small and the ball got out of the vessel of interest, the element size was 
incremented and segmentation was repeated locally, around the problematic 
regions.  Results have indicated that using a shape element, as opposed to a 
single pixel, does not sacrifice segmentation accuracy at the hands of feasibility 
given that our datasets are of sufficient resolution [35].  
3D Reconstruction:  
An in-house program was written at Georgia Tech to automatically mesh 
the given TCPC geometry and output the results into a software package called 
Geomagics, which was used to convert the point data into a set of triangular 
surface elements that define the geometry, as well as to clean up the geometry.  
This was then imported into a meshing program called Gambit, which was used 
to create an unstructured computational mesh from the elements that define the 
borders of the geometry.  In order to move entrance and exit effects away from 
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the region of interest, the inlets (SVC and IVC) were extended by 6 diameters 
and the outlets (LPA, RPA) by 3 diameters. 
 
4.3 CFD Solver 
The geometry was solved for the baseline input conditions described 
above initially using a first order solver at the baseline flow condition for each 
mesh density, thus ensuring that the solution is stable and not dependent on 
increasing mesh density.  Furthermore, the input and output flows were 
compared to their expected values.  Incase of any significant differences, the 
geometry and mesh were refined, as this usually implies inaccuracies or errors in 
the mesh.  If required, further refinements were made in the mesh density in 
order to ensure convergence to a stable solution.  Once the first order solution 
has been confirmed, a second order solver was used for each mesh density, as 
the second order solver provides a more accurate solution and power loss results 
that are consistent with in vitro data.  The second order solver was solved at the 
coarse, medium and fine mesh densities described above. 
Next the defined geometry was imported into FIDAP 8.5, which is the 
computational fluid dynamics package used to solve the flow through the 
geometry.  The baseline inlet flows were defined using the flows calculated from 
the MRI data.  The outlet flows were defined using the RPA/LPA flow ratio 
calculated from the MRI data (through-plane phase encoded velocity maps of the 
LPA and RPA flows).  This data was used to define the inlet and outlet 
conditions.  Three different mesh densities, designated coarse, medium and fine, 
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were created.  These consisted of roughly 100 thousand, 200 thousand, and 400 
thousand elements respectively in the geometry of interest, varying to some 
extent depending on the size and complexity of the geometry.  Results between 
mesh sizes were compared to assure relative independence of the solution on 
mesh density.  Further refinement or restructuring of the mesh was performed as 
needed if there is excessive solution dependence on mesh density. 
 
4.4 Evaluation of power loss 
There are two primary methods employed for calculating the power loss of 
internal flows: by the control volume method and by the calculation of the 
dissipation function.  The method employed in this study is the control volume 
method, as it has proved more robust in agreement with in vitro validation.  If we 
are given the control volume illustrated below where the solid lines represent the 
TCPC region of interest and the broken line the control volume, then the power 
loss can be calculated by integrating the energy flux over the surface of the 
control volume. 
QvpdSnuuupE
Surface
iijj ⎟⎠
⎞⎜⎝
⎛ +≅⎥⎦
⎤⎢⎣
⎡ += ∫ 22121 ρρ&  
where E&  is the range energy loss, p  is the pressure at the volume surface, ρ  is 
fluid density, ju  is the velocity component in the j direction, in   is the unit normal 
in the i direction, dS  is the surface differential operator, v is the average velocity 
at the surface, and Q is the total flow rate at that surface.  
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Figure 4.4.1: A simplified model of the TCPC with the inlet IVC and SVC and the outlet 
LPA and RPA. 
 
 
 
In practical terms, the total energy for each surface is calculated by 
summing the inertial and static energy components at each surface.  From this, 
the net power loss can be calculated by simply subtracting the outlet power from 
the inlet power: 
rpalpaIVCSVCdelta EEEEE &&&&& −−+=  
where deltaE&  is the net rate of energy loss in the control volume. 
In a patient, the pulmonary flow-split is imposed by the resistance 
encountered by the blood as it goes through the lungs.  In order to assess the 
quality of the lung perfusion associated with each TCPC design a simple lump 
parameter model was implemented to incorporate the pulmonary vascular 
resistance (PVR). Given the small size of the capillaries, the linear Darcy’s model 
holds for the capillary lung flows: 
QSVC, PSVC
QLPA, PLPA 
QIVC, PIVC
QRPA, PRPA
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PVLPALPALeft PPQR −=∗  
PVRPARPARight PPQR −=∗  
where LeftR and RightR  are the left and right lung resistances, LPAQ  and RPAQ  are the 
flow rates through the LPA and the RPA, and LPAP , RPAP  and PVP  are the 
pressures in the LPA, RPA and in the pulmonary venous return. Thus,  
RPALPARPALPA
Right
Left
Right PPQQR
R
R −=⎟⎟⎠
⎞
⎜⎜⎝
⎛ −∗  
The difference in pressure between the two pulmonary artery 
branches, RPALPA PP −  is known from the experimental measurements as a function 
of flow split, LPARPA QQ . This can thus be solved with respect to the pulmonary 
flow split. The solution provides the amount of blood going to the left and right 
lung when the TCPC under study is coupled with the two PVR values LeftR  
and RightR .  In this study we have focused on the physiological operating point of 
equal lung vascular resistance (EVLR) by setting both LeftR  and RightR  to 2.0 
Wood units.   
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 The model being shown as an example here is CHOP55 ( model 
number 55 obtained from the Children’s Hospital of Philadelphia) which is an 
extra-cardiac TCPC with a bifurcated SVC (the left and the right SVC), called the 
bilateral SVC TCPC.  
 
 
 
 
Figure 4.5: Anterior view of CHOP55; this model is a bifurcated SVC TCPC with the 
right and left SVCs as shown. 
  
 
 
A detailed protocol was developed for the entire mesh generation process 
and is attached in the appendix.  Models were first prepared in Geomagic by first 
cutting off excessive vessel regions by using a normal-plane sectioning tool.  
Specifically, CHOP55 was prepared using 450 patches with a curvature of 0.7.  
After further smoothing and refining, especially in regions of high curvature, the 
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file was exported for mesh generation. The goal of refining areas of high 
curvature was to provide finer surfaces which would result in better meshes and 
thus better CFD results.   
After importing the file rendered by Geomagic into Gambit, the patches 
were merged leaving only the inlet/outlet face edges.  The vessels were 
extended to a length equal to four times their respective diameters to allow for a 
more accurate estimation of fluid velocity at the actual inlets/outlets of the 
vessels at the TCPC connection.  The IVC, LSVC, RSVC, RPA, and LPA were 
extended for about six times the diameters for the inlets and three times the 
diameters for the outlets respectively.  At this point, there were six volumetric 
entities, one for each vessel and one for the TCPC body.  After the vessels were 
extended the mesh was generated using an inlet/outlet mesh spacing of 0.2 and 
an interior spacing of 1.2 at the edges.  After meshing the surfaces using a Tri 
element type and the volumes using a Tet/Hybrid element with t-Grid type, about 
600,000 elements were generated that were used by FIDAP for CFD simulation 
purposes.  
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Figure 4.6: CHOP55 in Gambit with the vessel extensions and mesh.  At this 
point, the file is complete and is prepared for CFD.  The local coordinate systems 
created for vessel extension can also be observed at the TCPC inlets/outlets. 
 
 
 
After mesh generation was completed in Gambit, the model was used in 
FIDAP for CFD simulation.  The table below shows the values obtained from the 
first two single-iteration trials of FIDAP, which were used to set the simulation 
conditions up for the 6,000 iterations that ran for nearly seven days.  
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Table 4.1: Input velocity calculations based on MRI flows for model CHOP89. The input 
velocities for the LPA and the RPA are not relevant as pressure boundary conditions are 
applied there. 
 
 
Limb Area (m2) 
MRI Flow 
(m3/s) 
Totals at 
VCs and 
PAs 
Input Velocity 
(m/s) 
SVC 1.64047E-04 0.9805 2.63630 0.09961582 
IVC 3.19508E-04 1.6558  0.08637230 
LPA 7.70802E-05 0.8239 2.0018 0.23461435 
RPA 1.36991E-04 1.1779  0.18872887 
 
 
 
 
y = -198.93x + 120.04
R2 = 1
y = -327.73x + 186.51
R2 = 1
0.00
5.00
10.00
15.00
20.00
25.00
0.49 0.49 0.50 0.50 0.51 0.51 0.52 0.52 0.53
Series1
Series2
Linear (Series1)
Linear (Series2)
 
Figure 4.7: Initial analysis on model CHOP55 to determine the left and right lung 
pressure boundary conditions at equal lung resistance, MRI flow splits and at 50-50 flow 
splits. A detailed explanation of the linear relationship between the LPA and RPA 
pressure differences and flow splits is included in Appendix C 
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These values were then used to run the 6,000 iteration simulation which 
ran for about one week.  At the end of the 6,000 iterations, the model was put 
through a post-processor and setup for analysis using Tecplot. 
 
Table 4.2: Summary of available data 
 
 
Age BSA CO CI RV LV 
All 10.2 ± 4.5 1.14 ± 0.42 3.3 ± 1.2 3.0 ± 0.9 5 6 
EC 6.6 ± 2.2 0.78 ± 0.24 2.5 ± 1.0 3.2 ± 1.1 3 2 
IC 13.2 ± 3.7 1.4 ± 0.28 3.9 ± 1.1 2.8 ± 0.8 3 3 
p-value < 0.01 < 0.01 N.S. N.S.     
 
 
 The results obtained after about 6000 iterations for each model and 
condition in FIDAP were copied onto an Excel sheet where the power losses 
were calculated by plugging in the pressures obtained into the formula for power 
loss. 
 
4.5 The Student’s t-test: 
 The t-test assesses whether the means of two groups are statistically 
different from each other. The t distribution is a family of curves in which the 
number of degrees of freedom specifies a particular curve. The number of 
degrees of freedom is the number of independent observations that were made 
in a sample minus 1 (n-1). It is used to validate a null hypothesis that there is no 
effective difference between the observed sample mean and the hypothesized 
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mean. The test statistic value t is calculated and if the observed t-value is more 
extreme than the critical value determined by the appropriate reference 
distribution, the null hypothesis is rejected.  
The formula for the t-test is a ratio. The top part of the ratio is just the 
difference between the two means or averages. The bottom part is a measure of 
the variability or dispersion of the scores. The two groups were analyzed for each 
flow split condition described above for power loss and normalized power loss.  
The Extra-cardiac and Intra-cardiac Fontans were compared using a two-tailed 
Student t-test with a threshold p-value of 0.05. This test was run using the basic 
Student’s t-test analysis package available in Microsoft Excel.  
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CHAPTER 5: RESULTS 
 
 
 
5.1 Power Loss in the TCPCs 
The comparison of power losses between the intra-atrial and the extra-
cardiac Fontans was undertaken for 6 models of the former and 5 of the latter.  
 
 Wood units which were used to specify the resistances are hybrid 
reference units used in pediatric cardiology and are defined as: 
1 Wood Unit (W.U) = 1 mmHg/ [L/min/m2] 
  
Table 5.1: The final power loss values (in mW) obtained for each of the model. IC 
represents intra-atrial TCPC and EC represents the extra-cardiac TCPC. 
 
  
Age  BSA CO  CI  Ventricular  
Head 
Loss  Resistance  
Model 
Type years M2 L/min L/min/m2 morphology MR 
splits 
mmHg 
MR splits  
W.U 
         
CHOP18 IC 11.26 1.23 2.45 1.99 R 2.71 1.36
CHOP22 IC 9.89 1.22 2.95 2.42 R 1.15 0.48
CHOP25 IC 18.11 1.58 3.74 2.36 R 1.3 0.55
CHOP31 IC 10.96 1.89 5.04 2.67 L 2.49 0.93
CHOP34 IC 11.35 1.19 5.24 4.4 L 2.02 0.46
CHOP37 IC 17.69 1.49 4.1 2.75 L 2.07 0.75
CHOP33 EC 8.83 0.69 3.52 5.1 R 1.59 0.31
CHOP55 EC 4.73 0.63 1.49 2.37 R 0.29 0.12
CHOP88 EC 4.05 0.54 1.47 2.7 L 0.44 0.16
CHOP89 EC 6.99 0.87 2.64 3.02 L 0.47 0.15
CHOP90 EC 8.62 1.15 3.44 2.99 L 0.45 0.15
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Table 5.2: Shows the mean and standard deviation calculations for the pulmonary lung 
resistances for each Fontan type at three conditions, the age, body surface area (BSA), 
cardiac output (CO) and cardiac index (CI) of the patient  
 
 
Model Fontan TypPL50-50 PLRl=RR Plmri Age BSA CO CI
CHOP18 I 10.24065 2.527248 6.022347 11.2637 1.23 2.45 1.99187
CHOP22 I 1.978085 1.646251 2.55585 9.889269 1.22 2.948215 2.41657
CHOP25 I 3.2553 2.8793 2.8793 18.11347 1.584649 3.7425 2.361722
CHOP31 I 6.693 5.051 5.529 10.95616 1.89 5.0406 2.666984
CHOP34 I 4.4863 4.4863 4.4863 11.34703 1.19 5.2409 4.404118
CHOP37 I 6.25 3.31 4.6 17.69132 1.49 4.0959 2.748926
CHOP33 E 2.08 2.08 3.53 8.833333 0.69 3.521668 5.103867
CHOP55 E 0.4744 0.4638 0.6517 4.733562 0.63 1.4938 2.371111
CHOP88 E 1.138 0.6202 0.9738 4.053196 0.544 1.4665 2.695772
CHOP89 E 1.04 1.04 1.04 6.989041 0.872 2.6363 3.02328
CHOP90 E 0.3994 0.3518 1.0077 8.620091 1.152 3.441 2.986979
Mean 3.457739 2.223264 3.025091 10.22638 1.135695 3.279762 2.9792
SD 3.145446 1.604453 1.954896 4.518739 0.423 1.249055 0.939141
 
 
 
5.2      Results for the student’s t-test: 
For a total of 6 intra-atrial and 5 extra-cardiac TCPC models, the power 
loss comparison was found to be significant (p < 0.05). The following table 
illustrates the t-test comparison between the EC and IC power losses in each of 
the cases studied. 
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Table 5.3: Final results for a student’s t-test comparison of the power losses between 
intra-atrial and extra-cardiac TCPCs at 50-50 flow splits, equal lung resistances and MRI 
flow splits.   
 
Head Loss 50% Rl=Rr=2.0 W.U. MRI 
EC 0.136 0.117 0.181 
IC 0.985 0.546 0.755 
p-value 0.028 0.001 0.006 
    
SD 0.058 0.052 0.074 
SD Interval 0.718 0.179 0.348 
 
 
 
Head Loss (mmHg) by Flow Split and Fontan Type
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p < 0.01
p < 0.01
p < 0.01
Error Bars are ± 1 S.D.
p-values represent  comparison
between EC and IC for given flow split 
 
Figure 5.1: Overall comparison of head losses (in mmHg) by flow splits and Fontan 
types. The yellow bars indicate EC and the red bars indicate the IC TCPCs. The p-
values represent the comparison between EC and IC for a given flow split. 
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Figure 5.2: Comparison of effective resistances (in Wood units) for EC and IC Fontan 
types for a given flow split. 
 
 
 
  
5.3 Streamlines and Flow Visualization Results  
 The three dimensional visualizations of the flow fields were obtained by 
exporting the FIDAP flow values into Tecplot. The following figure shows the 
simulation results for the MRI-derived flow splits, including streamlines, pressure 
contours (in mmHg) and dissipation plots (in mW/cm3) for a sample EC model 
CHOP55.  
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Figure 5.3: Streamline plot for CHOP55. Red and orange lines represent IVC flow; blue 
and green denote SVC flows and the pink lines, the LSVC flow. 
 
 
 
 The red and orange streamlines denote IVC flow, green and blue SVC 
flow, and purple and pink LSVC flow if present (like in the case of CHOP55, 
which is a bifurcated SVC TCPC).   
 In general, IVC flow is directed to the LPA and the SVC flow towards the 
RPA in case of IC models. For the EC models, IVC flow is more directed toward 
the RPA, and SVC flow to the LPA.  This may in part explain the differences in 
power loss between the EC and IC geometries.  Also of interest is the increased 
SVC flow into the IVC in EC models, whereas IVC flow tends to penetrate into 
rsvc lsvc 
rpa 
ivc
lpa 
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the SVC for most IC models. Another sample streamline plot is shown below, this 
time an IC model, CHOP37. 
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Figure 5.4: Streamlines and Pressure Contours for CHOP37, an IC model. 
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CHAPTER 6: DISCUSSION 
  
While clearly there is an observable trend with respect to power losses in 
extra-cardiac and intra-atrial TCPCs, there is still a need to analyze a larger 
database of patients. More data sets are required before generalizations can be 
made.  The overall goal of this study was to develop methods of evaluating power 
losses in the Fontan connection and to determine the effect of these power losses 
on clinical performance. It is the hope that this research will ultimately lead to 
improved post-operative functional status and late survival.  
 
6.1 Flow Patterns in the TCPC 
In general, the IVC flow is directed to the LPA and the SVC flows towards 
the RPA in case of IC models. For the EC models, the IVC flow is more directed 
toward the RPA, and SVC flow to the LPA.  This may in part explain the 
differences in power loss between the EC and IC geometries.  Also of interest is 
the increased SVC flow into the IVC in EC models, whereas the IVC flow tends to 
penetrate into the SVC for most IC models. Minimizing energy loss in the 
systemic venous pathway of the Fontan circulation is clearly important in 
optimizing cardiac energetics.  
Anatomic information gained through cardiac MRI can be used to build the 
CFD model and the velocity mapping can be a tool to validate the model. A 
number of assumptions were built into the CFD models including the absence of 
vessel wall compliance and respiratory variation. Nevertheless, it was shown 
previously that there was good agreement between the CFD model and the MRI 
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in vivo data. CFD models of the TCPC based on preoperative anatomy could be 
used to predict postoperative hemodynamics. This is critical, as CFD could then 
be used as a predictor of post-operative hemodynamics and thus outcome. 
Another significant direction of this research is to compare the power 
losses and resistance indices in simulated exercise conditions using CFD 
methods. This can provide new and important insights into patient mortality and 
performance in later years. Also, a comprehensive data set of the patients 
operated upon from all the collaborative institutes and hospitals is being prepared 
so that templates can be created based upon the patient’s specific TCPC 
anatomies. Qualitative and quantitative comparisons between the flow fields can 
be made at rest and exercise, including vortex formation, flow collision, flow skew 
and wall shear, using this data.  
 
6.2 Magnetic Resonance Imaging and Numerical Methods 
Magnetic Resonance Imaging does act as a decent tool in acquiring the 
images that can be developed into reasonably accurate 3-D geometry models 
and obtaining the flow information. However, a major detriment in accomplishing 
exercise MRI data would be during performing the MRI scans to obtain adequate 
images and velocity maps during the acquisition, owing to the movement of the 
patient. There is a need to experiment with different methods of securing the 
upper torso of the patient in the scanner during exercise to prevent shift.  If 
excessive movement occurs during exercise, additional scout images may be 
required to obtain adequate slice position for accurate flow quantification.  
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This study demonstrates the feasibility of analyzing flow fields in 
anatomically accurate models using numerical approaches. Future development 
in this area should include a combined perspective of both in vivo (based on 
patient MRI data), in vitro and computational approaches. Studying the power 
loss comparisons between Glenn and Hemi-Fontan procedures would yield a 
significant understanding of the energy dissipation dynamics in the TCPCs in 
general.  
 
6.3 Image Processing and Reconstruction 
The TCPC anatomies in this study were reconstructed from patient MRI. 
As explained in the methods section, this process required interpolating the raw 
data, segmenting the vessels of interest, generating the three-dimensional 
volumes and performing some design operations in order to adapt the true 
anatomy to meet the and numerical needs. The little compromise between 
having an accurate anatomical model and the exact patient anatomy requires 
complicated analysis to quantify. Development of a code to quantify and control 
this deviation is needed in the future. 
 
6.4 Future Directions 
It would also be an interesting to assess and model the flow pulsatility 
within the TCPC connection. However, a complicated CFD model that 
incorporates the factor of pulsatility should first be validated using in vitro 
experiments. A code developed using commercially available software CFD 
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packages and an in-house code is probably needed to accomplish a protocol that 
allows the researcher to consider the pulsatility factor of the blood flow. Overall, 
this study hopes to demonstrate the effective usage of Biomedical Engineering 
techniques that can help the surgeon rationally decide and choose a particular 
surgical protocol in the clinical setting and further development and research in 
this area will definitely aid to this purpose. 
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APPENDIX A: LIST OF ABBREVIATIONS 
 
 
 
TCPC  Total Cavo-pulmonary Connection 
IVC  Inferior Vena Cava 
SVC  Superior Vena Cava 
LPA  Left Pulmonary Artery 
RPA  Right Pulmonary Artery 
LSVC  Left Superior Vena Cava 
RSVC  Right Superior Vena Cava 
CFD   Computational Fluid Dynamics 
MRI  Magnetic Resonance Imaging 
PA  Pulmonary Artery 
VC  Vena Cava 
EPVR  Equal Pulmonary Vascular Resistance 
CHOP  The Children’s Hospital of Philadelphia 
RA  Right Atrium 
LA  Left Atrium 
RV  Right Ventricle 
LV  Left Ventricle 
VEC MR Velocity-Encoded Cine Magnetic Resonance Imaging 
ROI  Region of Interest 
ACGI  Adaptive Control Grid Interpolation 
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APPENDIX B: CFD PROTOCOL 
 
 
 
Mesh Generation Protocol 
Gambit 
 
A Linux based computer was used for all of the CFD protocols. In the command 
terminal, we type ‘gambit –id chopX_surface –dev XWIN’. 
 
I.  Merging Faces 
File > Import > IGES > Browse > FILE  
(Virtual Cleanup, Value = 1, ACCEPT) 
Geomerty > Surface > Merge Faces (virtual forced, merged edges) > 
MERGE FACES 
 (At the end, there should be FOUR boundaries and the wall) 
 
II. Boundary Extensions 
 Vertex > On Edge (virtual) > PICK FOUR POINTS 
    (4 = 1 already there + 3 additions, to estimate 
diameter) 
 Vertex > Summarize Vertices > PICK A POINT 
(Find the distance between two parallel points) 
 
(Input values obtained into spreadsheet for easy calculations.  The following is 
the basic equation required:  Length = sqrt[ (x1-x2)2 + (y1-y2) 2 + (z1 – z2) 2 ] ) 
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III. Coordinate System 
Delete one Vertex > Operations > Coordinates > Create Coordinate System > 
Verticies (with Z-axis pointing in) > Delete another vertex> Edge > Split Edges > 
Select edge > Split with Vertex > Select either vertex > APPLY 
 
Geometry (face) > Surface > Sweep Edges (vectors) > Select both edges > 
DEFINE > Click on coordinate system > -Z (negative Z) > Input MAGNITUDE 
(Mag = 4 * average diameter) > OK > APPLY 
 
Geometry > Surface > Merge Edges > MERGE EDGES OF THE EXTENSION 
 
Surface > Wire frame > New Edge (select outside edge) > APPLY 
 
Volume > Stitch Faces > Select the three new faces (outer opening, inner 
opening, the wall between them) 
 
REPEAT STEPS II & III FOR OTHER REMAINING BOUNDARIES 
 
IV. Grids 
Mesh > Edges > Mesh Edges > Select Edge > Interval Count or Interval Spacing  
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 If using interval spacing:  0.2-0.3 @ inlets/outlets (exterior) 
     0.8-1.2 @ connection (interior) 
 
> Surfaces > Select all Faces > Elements: Tri > Apply 
> Volume > Select all Volumes > Elements: Tet/Hybrid (type: t-Grid) > Apply 
 
V. Label CFDs 
Solver > FIDAP > Zones Command > Specify Boundary Types > Add > Specify 
the face > NAME > APPLY 
 
FIDAP Procedure 
 
1. Connect to drboz.bme.gatech.edu 
2. Select node based on availability (check http://drboz.bme.gatech.edu) 
3. Go to folder /var/scratch 
4. Create subfolder for project 
5. Copy your mesh file (*.FDNEUT) as well as clinical_chop.FIPREP and 
*.FDREAD files to folder 
6. Open clinical_chop.FIPREP using command: “vi clinical_chop.FIPREP” 
a. Edit file name at beginning of file 
b. Change iteration number to “1” 
1. Edit text by pressing “I” first and exit insert mode by pressing 
“Esc” 
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2. Save and quit by typing “:wq!” 
7. Open post_pro.FDREAD using command: “vi post_pro.FDREAD” 
a. Edit file name 
8. Run FIDAP for one iteration by typing “nohup fidap -id MODEL -parallel -in 
clinical_chop.FIPREP &”  (MODEL = name of model being run) 
a. Once it is running, you can type “top” to check on the progress 
b. If the process ends abruptly and no *.FDCONV or *.FDPOST files 
are written to the directory you created, open the *.FISTAT file to 
check for errors  
1. Note: FIPREP file is case-sensitive for names such as 
branch, connection, etc.   
9. Once FIDAP runs the first iteration successfully, open FIDAP using “fidap 
–id MODEL  
a. In the FIDAP command prompt, type “READFILE (FILE = 
“post_pro.FDREAD”, NOINTERACTIVE, NOECHO) 
b. This will generate a file with the total face areas for each vessel 
(svc, ivc, lpa, rpa – in that order)   
c. Copy these face areas to the excel spreadsheet to calculate 
velocities using flow rates for your model from Fontan database on 
the website 
d. SVC and IVC input may not equal LPA and RPA output so 
determine the fraction going to LPA or RPA and then use the total 
input to determine an adjusted flow rate for PAs 
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1. To get out of FIDAP type “end” 
 
10. Open up the clinical_chop.FIPREP file and change the velocities for SVC, 
IVC, LPA, and RPA in the “CONS=” for each vessel using the same 
commands given in step 6 
a. SVC and IVC should have negative velocities as flow is into the 
connection and LPA and RPA velocities are positive as flow is out 
of the connection 
11. Remove all FIDAP files that were created in the directory except original 
mesh file (*.FDNEUT) and clinical_chop.FIPREP and *.FDREAD files.   
a. Easiest way to remove these files is to name your *.FDNEUT file 
differently than the name of your file folder and use the command 
“rm MODEL.*” which will remove all files with that name 
12. Repeat steps 8 and 9 
a. Instead of looking at the FIDAP result for total face area, record the 
total flow rates given for each vessel in the spreadsheet under the 
column ‘CFD Flow Rate 1st Itr’. 
b. The spreadsheet is set up to give you an adjusted velocity under 
the ‘CFD velocity’ column.  (Keep the sign of the velocities the 
same in the FIPREP file [(-) for SVC/IVC, (+) for LPA/RPA]. 
c. Replace the original velocities entered in step 9 with these adjusted 
velocities into the clinical_chop.FIPREP file  
13. Repeat step 11 and then steps 8 and 9 again  
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a. Check that the total flow rates from FIDAP correspond to your 
target flow rates calculated from the Fontan database information 
14. If everything agrees, edit the clinical_chop.FIPREP file to have it make 
6,000 iterations.  (we had changed it to only 1 interation earlier) 
15. Repeat step 10 to delete old files and then run step 7 
a. This may take 1-3 days to complete  
b. The “nohup” command allows you to close the ssh client by just 
closing the window (don’t type exit, end, etc) 
c. You can still check on the progress by typing “Top”  
1. You can exit top by pressing “q” 
d. The number of iterations that have run so far at any given point of 
time can be viewed using the command “tail MODEL.FDCONV 
 
Notes:  
1. The whole CFD procedure was run on Linux based computers or windows 
based PCs that had some kind of a Linux client installed on them. 
2. Dr. Kerem Pekkan provided this protocol. 
3. The FDNEUT files were prepared from Gambit. The FDNEUT file is a text file 
that was converted from a DOS to Unix format converter incase of a format 
mismatch error. I used Cream/Vim software that is available for free download 
online.  
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APPENDIX C: RELATIONSHIP BETWEEN LUNG RESISTANCE AND FLOW 
SPLITS 
 
 
 
The following mathematical analysis explains the relationship between the 
flow splits and lung resistance. We get a linear relationship between the pressure 
difference between the LPA and RPA and the flow splits. 
 
Plpa - Prpa = -A (Ql/Qt) + B 
 
Plpa = pressure at LPA of Fontan connection 
Prpa = pressure at RPA of Fontan connection 
Ql = flow to LPA 
Qt = total flow (obtained from CMR)  
 
Also 
Plpa = Ql*Rl + Pla 
Prpa = Qr*Rr + Pla 
 
Qr = flow to the RPA 
Rr = right lung resistance 
Rl = left lung resistance 
Pla = left atrial pressure, which cancels out 
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So  
 
Ql*Rl - Rr*Qr = -A(Ql/Qt) + B 
Qr = Qt - Ql 
QlRl - Rr(Qt-Ql) = -(A/Qt)Ql + B 
Ql [Rl + Rr + A/Qt] = B + RrQt 
Ql = [B + RrQt] / [Rl + Rr + A/Qt] 
 
We know Qt from the MRI data, Rl and Rr are defined, and A and B are derived 
empirically from the pressure runs at a given Qt. Plotting this for any A, B, and 
Qt, as Rl = Rr gets larger, Ql goes to 0.5Qt 
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APPENDIX D: CFD FIPREP AND FDREAD CODE FILES 
 
 
 
The FIPREP file prepares the output FDNEUT files that were obtained 
from GAMBIT into a format readable by FIDAP. It also acts as the window to 
input the initial velocity conditions into FIDAP. 
 
/ ***************************************************************** 
/ Disclaimer: This file was written by GAMBIT and contains 
/ all the continuum and boundary entities and coordinate systems 
/ defined in GAMBIT. Additionally, some frequently used FIPREP 
/ commands are added. Modify/Add/Uncommment any necessary commands. 
/ Refer to FIPREP documentation for complete listing of commands. 
/ ***************************************************************** 
/ 
/          CONVERSION OF NEUTRAL FILE TO FIDAP Database 
/ 
FICONV( NEUTRAL ) 
INPUT( FILE="C:\Documents and Settings\FELLOWSRM.000\Desktop\Ravi 
Share\newchop55\chop55g.FDNEUT" ) 
OUTPUT( DELETE ) 
END 
/ 
TITLE 
chop55g 
/ 
FIPREP 
/ 
/          PROBLEM SETUP 
/ 
PROBLEM (3-D, LAMINAR, NONLINEAR, ISOTHERMAL) 
EXECUTION( NEWJOB ) 
PRINTOUT( NONE ) 
DATAPRINT( CONTROL ) 
/ 
/          CONTINUUM ENTITIES 
/ 
ENTITY ( NAME = "extension", FLUID, PROPERTY = "extension" ) 
ENTITY ( NAME = "connection", FLUID, PROPERTY = "connection" ) 
/ 
/          BOUNDARY ENTITIES 
/ 
ENTITY ( NAME = "wall", PLOT ) 
ENTITY ( NAME = "rsvc ", PLOT ) 
ENTITY ( NAME = "lsvc", PLOT ) 
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ENTITY ( NAME = "rpa", PLOT ) 
ENTITY ( NAME = "lpa", PLOT ) 
ENTITY ( NAME = "ivc", PLOT ) 
ENTITY ( NAME = "inlet_rsvc", SLIP, PROPERTY = "inlet_rsvc" ) 
ENTITY ( NAME = "outlet_rpa", SLIP, PROPERTY = "outlet_rpa" ) 
ENTITY ( NAME = "outlet_lpa", SLIP, PROPERTY = "outlet_lpa" ) 
ENTITY ( NAME = "inlet_lsvc", SLIP, PROPERTY = "inlet_lsvc" ) 
ENTITY ( NAME = "inlet_ivc", SLIP, PROPERTY = "inlet_ivc" ) 
/ 
/          LOCAL COORDINATE SYSTEMS DEFINED 
/ 
/COORDINATE ( SYSTEM = 2, MATRIX,CARTESIAN ) 
/0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 
1.000000 0.000000 0.000000 0.000000 1.000000 
/COORDINATE ( SYSTEM = 3, MATRIX,CARTESIAN ) 
/76.056922 -77.685694 -10.841946 0.963596 -0.239704 -0.118425 -0.266894 
-0.888611 -0.373013 -0.015821 0.391040 -0.920237 
/COORDINATE ( SYSTEM = 4, MATRIX,CARTESIAN ) 
/123.607138 -72.866906 -25.038726 -0.114733 -0.979283 -0.166855 -
0.931101 0.047467 0.361659 -0.346246 0.196853 -0.917258 
/COORDINATE ( SYSTEM = 5, MATRIX,CARTESIAN ) 
/123.433771 -60.918318 -54.726367 0.262531 -0.826394 -0.498147 0.554448 
-0.293325 0.778811 -0.789724 -0.480659 0.381186 
/COORDINATE ( SYSTEM = 7, MATRIX,CARTESIAN ) 
/80.618898 -71.368684 -105.456099 0.959443 0.136709 0.246534 -0.138821 
0.990278 -0.008880 -0.245351 -0.025705 0.969093 
/COORDINATE ( SYSTEM = 8, MATRIX,CARTESIAN ) 
/69.784698 -52.810380 -59.737952 0.258764 -0.756999 -0.599995 0.906233 
0.405254 -0.120461 0.334339 -0.512565 0.790882 
/ 
/          SOLUTION PARAMETERS 
/ 
/SOLUTION( SEGREGATED = 50, CR, CGS, VELCONV = .001, NCGC = 1.E-6, SCGC 
= 1.E-6, SCHANGE = .0 ) 
/PRESSURE( MIXED = 1.E-8, DISCONTINUOUS ) 
/RELAX( HYBRID ) 
/OPTIONS( UPWINDING, , , ) 
/SCALE( VALUE = 1 ) 
/TIMEINTEGRATION( BACKWARD,NSTEPS = ,DT = 0,,, ) 
/POSTPROCESS( NBLOCKS =  ) 
/ 
/          MATERIAL PROPERTIES 
/ 
/ Partial list of Material Properties data 
/ 
DENSITY( SET = "extension", CONSTANT = 1 ) 
VISCOSITY( SET = "extension", CONSTANT = 1 ) 
/CONDUCTIVITY( SET = "extension", CONSTANT = 1 ) 
/SPECIFICHEAT( SET = "extension", CONSTANT = 1 ) 
/ 
DENSITY( SET = "connection", CONSTANT = 1 ) 
VISCOSITY( SET = "connection", CONSTANT = 1 ) 
/CONDUCTIVITY( SET = "connection", CONSTANT = 1 ) 
/SPECIFICHEAT( SET = "connection", CONSTANT = 1 ) 
/ 
/SLIPCOEFFICIENT( SET = "inlet_rsvc", CONSTANT = 0, VELOCITY, UT = 0, 
PRESSURE = 0 ) 
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/ 
/SLIPCOEFFICIENT( SET = "outlet_rpa", CONSTANT = 0, VELOCITY, UT = 0, 
PRESSURE = 0 ) 
/ 
/SLIPCOEFFICIENT( SET = "outlet_lpa", CONSTANT = 0, VELOCITY, UT = 0, 
PRESSURE = 0 ) 
/ 
/SLIPCOEFFICIENT( SET = "inlet_lsvc", CONSTANT = 0, VELOCITY, UT = 0, 
PRESSURE = 0 ) 
/ 
/SLIPCOEFFICIENT( SET = "inlet_ivc", CONSTANT = 0, VELOCITY, UT = 0, 
PRESSURE = 0 ) 
/ 
/          INITIAL AND BOUNDARY CONDITIONS 
/ 
/ICNODE( , CONSTANT = 0, ALL ) 
/ 
/BCNODE( , CONSTANT = 0, ENTITY = "wall" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "rsvc " ) 
/BCNODE( , CONSTANT = 0, ENTITY = "lsvc" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "rpa" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "lpa" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "ivc" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "inlet_rsvc" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "outlet_rpa" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "outlet_lpa" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "inlet_lsvc" ) 
/BCNODE( , CONSTANT = 0, ENTITY = "inlet_ivc" ) 
/ 
END 
/ 
CREATE( FIPREP,DELETE ) 
PARAMETER( LIST ) 
CREATE( FISOLV ) 
/RUN( FISOLV, FOREGROUND ) 
 
FDREAD Files: 
/ READFILE( FILE= "post_pro.FDREAD", NOINTERACTIVE , NOECHO ) 
/Postprocessing 
/ 
DEVICE(NOGRAPHICS) 
$case = "chop31" 
$f_pst = $case + ".FDPOST" 
$f_ux = $case + "_ux" + ".FPNEUT" 
$f_uy = $case + "_uy" + ".FPNEUT" 
$f_uz = $case + "_uz" + ".FPNEUT" 
$f_p = $case + "_p" + ".FPNEUT" 
/ 
/ 
FIPOST ( FILE= $f_pst ) 
NEUTRAL( FIPOST, UX, FILE= $f_ux ) 
NEUTRAL( FIPOST, UY, FILE= $f_uy ) 
NEUTRAL( FIPOST, UZ, FILE= $f_uz ) 
NEUTRAL( FIPOST, PRESSURE, FILE= $f_p ) 
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FLOWRATE( ENTITY="inlet_svc" ) 
FLOWRATE( ENTITY="inlet_ivc" ) 
FLOWRATE( ENTITY="outlet_lpa" ) 
FLOWRATE( ENTITY="outlet_rpa" ) 
/ FLOWRATE( ENTITY="outlet_fen" ) 
STRSPRINT( PRESSURE, ENTITY="inlet_svc" ) 
STRSPRINT( PRESSURE, ENTITY="inlet_ivc" ) 
STRSPRINT( PRESSURE, ENTITY="outlet_lpa" ) 
STRSPRINT( PRESSURE, ENTITY="outlet_rpa" ) 
/ STRSPRINT( PRESSURE, ENTITY="outlet_fen" ) 
END 
/ FILES(RENAME, FROM = "fid8.FDSTAT", TO = $fdstat) 
/ FILES(RENAME, FROM = "fid8.FDPOST", TO = $fdpost) 
/ IDENT(NAME="fid8",OLD) 
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